Kenvue Announces Participation in the Barclays Global Consumer Staples Conference
Get Alerts KVUE Hot Sheet
Join SI Premium – FREE
SKILLMAN, N.J.--(BUSINESS WIRE)-- Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company’s participation in the Barclays Global Consumer Staples Conference in Boston, Massachusetts. Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will participate in a fireside chat on Thursday, September 5, 2024, at 3:00 p.m. Eastern Time. A live webcast of the session will be available on investors.kenvue.com and a replay will be available on the website following the event.
About Kenvue
Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240823569733/en/
Investor Relations:
Jim Giannakouros, CFA
[email protected]
Media Relations:
Melissa Witt
[email protected]
Source: Kenvue
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CheckAlt and LoanPro Partner to Expand Payment Processing Capabilities for Lenders
- University Health Deploys Zebra Mobile Devices to Reduce Callback Times and Modernize Workflows
- SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share